500770-84-3 Usage
Uses
Used in Pharmaceutical Industry:
Boc-(S)-3-amino-3-(3-nitro-phenyl)-propanoic acid is used as a key intermediate in the synthesis of various peptide-based drugs. Its unique structure allows for the development of novel therapeutic agents with potential applications in treating a wide range of diseases and medical conditions.
Used in Biochemical Research:
In the field of biochemical research, Boc-(S)-3-amino-3-(3-nitro-phenyl)-propanoic acid serves as a valuable tool for studying the structure, function, and interactions of biological molecules. Its presence in complex organic molecules can provide insights into the mechanisms of various biological processes and contribute to the discovery of new therapeutic targets.
Used in Organic Synthesis:
Boc-(S)-3-amino-3-(3-nitro-phenyl)-propanoic acid is utilized as a building block in the synthesis of complex organic molecules. Its versatile structure allows for the creation of a wide range of compounds with diverse properties and applications, making it an essential component in the field of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 500770-84-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,7,7 and 0 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 500770-84:
(8*5)+(7*0)+(6*0)+(5*7)+(4*7)+(3*0)+(2*8)+(1*4)=123
123 % 10 = 3
So 500770-84-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2O6/c1-14(2,3)22-13(19)15-11(8-12(17)18)9-5-4-6-10(7-9)16(20)21/h4-7,11H,8H2,1-3H3,(H,15,19)(H,17,18)
500770-84-3Relevant academic research and scientific papers
CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS
-
Page/Page column 8; 19, (2020/06/01)
The present invention relates to novel pharmaceutical compounds comprising of an αvβ3 integrin antagonist, a linking unit comprising of L-Val – L-Pro – L-Asp cleavable by elastase, a polyethyleneglycol (PEG) spacer and a cytotoxic element, to processes for preparation thereof, to the use thereof for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals.
